Abivax nears $11 billion valuation after fundraising eases M&A pressure - Reuters
Abivax nears $11 billion valuation after fundraising eases M&A pressure Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPNlNyUXYxZE85cFdYaVdKSldIbHR1QVVxT2ZhOTUzcmo2c3dZSXZ6c2hGSWlYSXpUQzE0T0xIbU1vTjhyRVd4YW4xdmlNdVc0My1hWWNxR29vc0hMY3pLOUt6RzczSFc2T25IbTIyVklKR09zbGw0Q3NZeXVkSUhRUG9LcHdSSkZKYnhoUXlXR0hRc04wd2tUeXpDYXNScmZuQXRoV0p4WHhlTFVQZjEzUGF1Tm5PVFFfMWJVbk0wSQ?oc=5" target="_blank">Abivax nears $11 billion valuation after fundraising eases M&A pressure</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
BASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMNvidia-backed data centre firm scraps IPO as AI valuation concerns deepen
Firmus said it had made the decision due to "recent market volatility and prevailing market conditions".
October 9, 2026 at 04:06 AMEXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMApple names insider Steve Smith as new M&A chief, memo shows - Reuters
Apple names insider Steve Smith as new M&A chief, memo shows Reuters
October 8, 2026 at 07:46 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PM